Skip to main content

Table 5 Medications prescribed for outpatient use in tertiary and secondary care hospitals

From: Improved treatment and prognosis after acute myocardial infarction in Estonia: cross-sectional study from a high risk country

  Year 2001 Year 2007 Year 2011 P value for trend
% % %
Tertiary care hospitals n = 181 n = 290 n = 261  
 Aspirin 85.1 93.1 95.4 <0.001
 P2Y12-receptor inhibitors 18.2 64.8 72.8 <0.001
 Betablockers 71.3 80.0 85.4 <0.001
 ACEi/ARB 66.3 77.2 84.7 <0.001
 Statins 31.5 73.4 80.8 <0.001
 Nitrates 61.9 22.1 15.8 <0.001
Secondary care hospitals n = 163 n = 224 n = 184  
 Aspirin 79.8 82.6 91.3 0.004
 P2Y12-receptor inhibitors 0.6 10.7 32.8 <0.001
 Betablockers 68.7 80.9 82.8 0.001
 ACEi/ARB 37.4 68.9 68.3 <0.001
 Statins 14.7 37.3 65.6 <0.001
 Nitrates 85.3 58.2 41.4 <0.001
  1. ACEi angiotensin-converting enzyme inhibitors, ARB angiotensin II receptor blockers, P2Y12-receptor inhibitors – ticlopidine/clopidogrel/ticagrelol